There are occasions where non-transport of a patient after ALS treatment has begun occurs. This document serves as a best practice advisory. It does not, nor is it intended as medical direction, or to replace the authority of any medical director to create guidelines for clinical practice within his/her agency. It is strongly encouraged that each agency and its respective medical director should create a specific directive with respect to how these situations are to be handled.
It is considered that situations that result in non-transport pose a higher medical and legal risk to both the provider and patient. However, patients with capacity have the right to determine their medical treatment. This includes procedures, medication administration, and transport. The patient may choose to consent to all, some, or none of these options.
Should a situation arise where non-transport after beginning ALS treatment arises, it is recommended that online medical control be contacted as part of the decision process. Providers should refer to the specific expectations laid out by their respective medical directors.